At Merz Therapeutics, we understand that a strong culture is essential to our mission of improving healthcare. We are dedicated to fostering an environment where every team member feels valued and empowered. Together, we can make a significant impact and improve the lives of people living with movement disorders.
Merz Therapeutics’ Post
More Relevant Posts
-
Brilliant panel at the LaingBuisson Investing in healthcare conference with Michelle Tempest, Tess Isabelle Cosad and Asif Ahmed PhD FRSB discussing all things female health, female founders and the huge investment opportunities in these sectors!
We’re delighted to have such passionate speakers for our session titled ‘Emerging Markets across Women’s Health and FemTech’. Chair by Michelle Tempest of Candesic, she is joined by founders and CEOs from R8ER, MirZyme Therapeutics and Béa Fertility to discuss how more money can enter this market to improve an underappreciated healthcare service.
-
-
Today, technology isn't just advancing; it’s changing lives in profound ways. At Speranza Therapeutics, we are proud to offer the S.T. Genesis device, helping individuals reclaim their lives by easing opioid withdrawal symptoms. This is more than just a tool—it’s a beacon of hope for patients and healthcare providers. The opportunity to be part of a solution in this critical time gives me hope for the future. Together, we can harness the power of innovation for real, lasting change. Let’s keep pushing boundaries and make a positive impact. Check out the video below to learn more! #innovation #addictionmedicine #recovery #technology #healthcare #hope #change
How S. T. Genesis Works - Speranza Therapeutics
https://www.youtube.com/
-
Pharma should encourage diversity and inclusion within patient organizations to ensure that a broader range of perspectives and experiences are represented. This can lead to more comprehensive insights into patient needs, improved engagement with underrepresented communities, and ultimately better healthcare outcomes. #diversityinclusion #patients #diversity #cancercare #pharma #pharmaceuticalindustry
-
-
Revolutionizing healthcare with Digital Therapeutics! 🌐💊 Evidence-based, tech-driven solutions for managing and treating medical conditions. Learn more in todays #ManagedCareMondays!
-
Patient engagement has transformed the biopharma industry. We talked to leaders in the space for their perspective on where patient engagement is headed next and how to maximize the impact of this critical capability and voice: https://lnkd.in/eVmWU4sb
-
Founder M.S. Strategy Consulting & Market Access & Innovation & Healthcare Entrepreneur - MBA
Market Access Insights The upcoming Payer Annual Trend Report found a significant increase in vertical payer integration expected by 2026. Key areas of development include: ➡ Cancer drug coverage policy decisions ➡Manufacturer contracting for rebates and discounts ➡Internal sharing of medical and drug utilization data ➡Communications with cancer care providers Stay ahead with these transformative insights and understand how payers are gearing up for the future. 🔎 Read the full analysis here: https://lnkd.in/eUs_C2RF M.S. Strategy & Access Consulting #Healthcare #MarketAccess #VerticalPayers #Integration #HealthPolicy
-
-
Meet the 2024 co-chairs for DTA's Patient Engagement Task Group, Tim Campellone, PhD of Woebot Health and Cate Layne of Propeller Health! In an effort to keep the patient centered in conversations about digital therapeutics, DTA and its Patient Engagement Task Group members seek to define best-in-class standards for involving the patient in the development and launch of digital therapeutics, and to uncover barriers to their adoption by patients, payers, and regulatory bodies worldwide. Learn more about DTA's Task Groups here: https://lnkd.in/gHiRhE3J #DTA #DTx #digitaltherapeutics #patientengagement
-
-
💡 WEBINAR TODAY 💡 Join us at 1pm ET for an in-depth discussion on the regulatory and policy landscape of #RNA-based therapies. REGISTER HERE: https://lnkd.in/e7iAZQh3
-
-
Digital therapeutics can complement every part of delivery system
Digital therapeutics can complement every part of delivery system
healthcarefinancenews.com
-
A few weeks ago, I participated in a fun discussion on the future of digital therapeutics hosted by Jose Garcia! We largely focused on the elephant in the room of digital therapeutics - managing the awkward balance of different stakeholders and regulatory landscapes that are crucial to new tech, building ecosystem-wide solutions, and getting everyone in the health tech value chain on board. If you missed the chat and want to check it out, here's the link! https://lnkd.in/dnzTsctT
The Digital Therapeutics Ecosystem: And Why It Matters
radency.com
Hear, hear! 👏